Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP

Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP

Background/Aims This study was to evaluate the clinical significance of infusion-related reaction (IRR) of rituximab in diffuse large B-cell lymphoma (DLBCL) patients who received R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone) as a first-line chemotherapy. Methods T...

Full description

Bibliographic Details
Main Authors: Kyoung Min Cho, Bhumsuk Keam, Hyerim Ha, Miso Kim, Jae-Woo Jung, Woo-Jung Song, Tae Min Kim, Yoon Kyung Jeon, Hye-Ryun Kang, Dong-Wan Kim, Chul Woo Kim, Dae Seog Heo
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2019-07-01
Series:The Korean Journal of Internal Medicine
Subjects:
infusion-related reaction
rituximab
lymphoma, large b-cell, diffuse
prognosis
characteristics
Online Access:http://www.kjim.org/upload/pdf/kjim-2017-036.pdf

Internet

http://www.kjim.org/upload/pdf/kjim-2017-036.pdf

Similar Items